❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ Eivind Hovig's group ❭ Eivinds work calendar ❭

Eivinds work calendar

Scroll to top

Home Dept. of Tumor Biology Eivind Hovig's group

  • Eivinds work calendar
  • Total staff list
  • Wet-lab group
  • DNR Bioinformatics
  • Research interests
    • Mutation analysis
    • Gene therapy
    • DNA variation
    • Links
  • Publications
  • Company affiliations
  • Press (mostly in Norw.)
  • Inherited and Familial Cancer [Dominguez-Valentin]
  • Genomic Regulation for Precision Cancer Medicine Lab [Urbanucci]
  • Autophagy in cancer [Engedal]
  • DNA analysis and methods [Ekstrøm]

Recent publications

Dominguez-Valentin M (2025)
Comment on Building a hereditary cancer program in Colombia: analysis of germline pathogenic and likely pathogenic variants spectrum in a high-risk cohort
Eur J Hum Genet (in press)
DOI 10.1038/s41431-025-01853-6, PubMed 40295843

(2025)
Metachronous colorectal cancer risks after extended or segmental resection in MLH1, MSH2, and MSH6 Lynch syndrome: multicentre study from the Prospective Lynch Syndrome Database
Br J Surg, 112 (4)
DOI 10.1093/bjs/znaf061, PubMed 40231433

Padrik P, Tõnisson N, Hovda T, Sahlberg KK, Hovig E, Costa L, Nogueira da Costa G, Feldman I, Sampaio F, Pajusalu S, Ojamaa K, Kallak K, Tihamäe AT, Roht L, Kahre T, Lepland A, Sõber S, Kruuv-Käo K, Tamm M, Varghese J, Evans DG, AnteNOR and BRIGHT Research Consortia (2025)
Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores
Cancers (Basel), 17 (7)
DOI 10.3390/cancers17071056, PubMed 40227593



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)